Status:
COMPLETED
Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Basal Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Basal Cell Carcinoma (BCC) is the most common malignant growth in the world. Treatment is primarily surgical with the goal of excising the growth in its entirety. When pathology results show that this...
Eligibility Criteria
Inclusion
- All patients that underwent an incomplete BCC excision during the years 2008-2010.
Exclusion
- Patients that underwent an incomplete BCC excision and were subsequently referred to undergo a MOHS procedure.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2011
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01403480
Start Date
January 1 2008
End Date
February 1 2011
Last Update
July 27 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.